EXTON, Pa.--(BUSINESS WIRE)--April 24, 2006--Antares Pharma Inc. (Amex:AIS - News) announced today the development of the TecTix(TM) drug delivery system for topical and transmucosal delivery of active pharmaceutical agents. The TecTix system is based on transiently reducing the melting point of an active drug by using a combination of known chemical compounds as special permeation enhancers. Reducing the melting point of a drug with our TecTix system, typically results in increased skin permeation, which in the near term should allow Antares to develop novel products specifically targeted for proprietary dermatological and mucosal delivery applications.
